Estimation of effectiveness of interventions for malaria control in pregnancy using the screening method

International Journal of Epidemiology

Volumn 36, Issue 2, 2007, Pages 406-411

  Msyamboza, K ^a,b   Senga, E ^b   Tetteh Ashong, E ^a   Kazembe, P ^c   Brabin, B J ^a,d,e  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MALAWI   (Malawi)

^c KAMUZU CENTRAL HOSPITAL   (Malawi)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimalarials; Efficacy; Malaria; Pregnancy

Indexed keywords

FANSIDAR;

DATA SET; DISEASE CONTROL; DRUG PRESCRIBING; ESTIMATION METHOD; MALARIA; MATERNAL EFFECT; MONITORING; PREGNANCY; RELIABILITY ANALYSIS; VACCINATION;

ADULT; ANEMIA; ARTICLE; BED NET; DELIVERY; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; PLACENTA; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; SCREENING; SELF REPORT;

ANTIMALARIALS; BIRTH WEIGHT; FEMALE; HUMANS; INFANT, NEWBORN; MALARIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; TREATMENT OUTCOME;

EID: 34447314450     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl301     Document Type: Article

References (23)

1. World Health Organisation. Lives at risk: Malaria in pregnancy. Geneva, World Health Organisation, 2003.
2. Schulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial. Lancet 1999;353632-36.
3. van Eijk AM, Ayisi JG, ter Kuile FO et al. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malria in pregnancy in Western Kenya: A hospital-based study. Trop Med Int Health 2004;9:351-60.
4. Gamble L, Ekwaru JP, ter Kuile FO. Insecticide-treated bed nets for preventing malaria in pregnancy. Cochrance Database of Systematic Reviews 2006, Issue 2, Art. No:CD003755.
5. Parise ME, Ayisi JG, Nahlen B, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Amer J Trop Med H 1998;59:813-22.
6. Nosten F, Rogerson SJ. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 2004;20:425-532.
7. Plowe CV. Antimalarial drug resistance in Africa: Strategies for monitoring and deterrence. Curr Top Microbiol 2005;295:55-79.
8. Kalanda GC, Hill J, Verhoef FH, Brabin BJ. Comparative efficacy of chloroquine and sulphadoxine-pyrimethamine in pregnant women and children: A meta-analysis. Trop Med Int Health 2006;11 569-77.
9. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993;22:742-46.
10. Orenstein WA, Bernier RH, Dondero JT, Hinman AR, Marks JS, Bart KT et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-68.
11. Palmer SR. Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991;66:854-57.
12. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. Placental malaria: I. Pathological classification. Histopathology 1993; 22:211-18.
13. Verheoff FH, Brabin BJ, Chimsuku L, Kazembe P, Broadhead RL. Malaria in pregnancy and its consequences for the infant in rural Malawi. Ann Trop Med Parasitol 1999;93:S25-S33.
14. Brabin BJ, Verhoeff FH, Kazembe P, Chimsuku L, Broadhead R. Antimalarial drug policy in Malawi. Ann Trop Med Parasitol 1997;91 S113-15.
15. Ismail MR, Ordi J, Menendez C et al. Placental pathology in malaria: An histological, immunohistochemical and qualitative study. Human Pathol 2000;31:85-93.
16. Savage E. An evaluation of village based delivery of sulfadoxine-pyrimethamine for malaria control in pregnancy and the use of maternal anaemia and birthweight as indictors of malaria burden in pregnancy. PhD thesis. UK: University of Liverpool, 2004.
17. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-16.
18. Verhoeff FH, Brabin RJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL. An evaluation of the effects of intermittent sufladoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med and Parasitol 1998;92:141-50.
19. Howarth P. Haematological and parasitological parameters in a cohort of pregnant women in the Shire Valley. Masters in Tropical Medicine Dissertation. UK: University of Liverpool, 1990.
20. Msyamboza K, Amanor A, Kazembe P et al. In vivo parasitological response to sulphadoxine-pyrimethamine in pregnant women in Southern Malawi. Malawi Medical Journal 2007 (in press).
21. Mbaye A, Richardson K, Balajo B et al. A randomised, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Tropical Medicine and International Health 2006;11:992-1002.
22. McGready R, Davison BB, Stepniewska K et al. The effectiveness of Plasmodium falciparum and P.vivax infections on placental histopathology in an area of low malaria transmission. Amer J Trop Med H 2004;70:398-407.
23. Malaria Indicator Survey. Basic documentation for survey design and implementation. ORC Macro, Calverton, Maryland. 2005.